{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:29:10Z","timestamp":1786400950914,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"33","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Oncogene"],"published-print":{"date-parts":[[2026,9,1]]},"DOI":"10.1038\/s41388-026-03871-0","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:26:30Z","timestamp":1783668390000},"page":"3427-3438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ESRP1-regulated DNMT3B isoform switching determines the malignant potential of pancreatic cancer"],"prefix":"10.1038","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0695-1275","authenticated-orcid":false,"given":"Eunji","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-7951-9666","authenticated-orcid":false,"given":"Hyeyeon","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1202-1808","authenticated-orcid":false,"given":"Junil","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin Muk","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taehong","family":"Min","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinah","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoungwha","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pyunggang","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjung","family":"Son","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Ooshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daeun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeongeun","family":"Im","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wooil","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideyuki","family":"Takeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7090-537X","authenticated-orcid":false,"given":"Ja-Lok","family":"Ku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbeom","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3405-7817","authenticated-orcid":false,"given":"Toshikazu","family":"Ushijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Jung","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daechan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6210-4927","authenticated-orcid":false,"given":"Seok Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4335-8793","authenticated-orcid":false,"given":"Seong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"key":"3871_CR1","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17\u201348.","journal-title":"CA Cancer J Clin"},{"key":"3871_CR2","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.cell.2011.11.060","volume":"148","author":"H Haeno","year":"2012","unstructured":"Haeno H, Gonen M, Davis MB, Herman JM, Iacobuzio-Donahue CA, Michor F. Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies. Cell. 2012;148:362\u201375.","journal-title":"Cell"},{"key":"3871_CR3","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2011.12.021","volume":"148","author":"DA Tuveson","year":"2012","unstructured":"Tuveson DA, Neoptolemos JP. Understanding Metastasis in Pancreatic Cancer: A Call for New Clinical Approaches. Cell. 2012;148:21\u201323.","journal-title":"Cell"},{"key":"3871_CR4","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.tcb.2018.12.001","volume":"29","author":"I Pastushenko","year":"2019","unstructured":"Pastushenko I, Blanpain C. EMT Transition States during Tumor Progression and Metastasis. Trends in Cell Biology. 2019;29:212\u201326.","journal-title":"Trends in Cell Biology"},{"key":"3871_CR5","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.cell.2016.06.028","volume":"166","author":"MA Nieto","year":"2016","unstructured":"Nieto MA, Huang RY-J, Jackson RA, Thiery JP, EMT: 2016. Cell. 2016;166:21\u201345.","journal-title":"Cell"},{"key":"3871_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gene.2004.10.022","volume":"344","author":"S Stamm","year":"2005","unstructured":"Stamm S, Ben-Ari S, Rafalska I, Tang Y, Zhang Z, Toiber D, et al. Function of alternative splicing. Gene. 2005;344:1\u201320.","journal-title":"Gene"},{"key":"3871_CR7","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.molcel.2009.01.025","volume":"33","author":"CC Warzecha","year":"2009","unstructured":"Warzecha CC, Sato TK, Nabet B, Hogenesch JB, Carstens RP. ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell. 2009;33:591\u2013601.","journal-title":"Mol Cell"},{"key":"3871_CR8","doi-asserted-by":"publisher","first-page":"3286","DOI":"10.1038\/emboj.2010.195","volume":"29","author":"CC Warzecha","year":"2010","unstructured":"Warzecha CC, Jiang P, Amirikian K, Dittmar KA, Lu H, Shen S, et al. An ESRP-regulated splicing programme is abrogated during the epithelial-mesenchymal transition. EMBO J. 2010;29:3286\u20133300.","journal-title":"EMBO J"},{"key":"3871_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1892","volume":"3","author":"T Yae","year":"2012","unstructured":"Yae T, Tsuchihashi K, Ishimoto T, Motohara T, Yoshikawa M, Yoshida GJ, et al. Alternative splicing of CD44 mRNA by ESRP1 enhances lung colonization of metastatic cancer cell. Nat Commun. 2012;3:883.","journal-title":"Nat Commun"},{"key":"3871_CR10","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1038\/onc.2013.392","volume":"33","author":"J Ueda","year":"2014","unstructured":"Ueda J, Matsuda Y, Yamahatsu K, Uchida E, Naito Z, Korc M, et al. Epithelial splicing regulatory protein 1 is a favorable prognostic factor in pancreatic cancer that attenuates pancreatic metastases. Oncogene. 2014;33:4485\u201395.","journal-title":"Oncogene"},{"key":"3871_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2017.87","volume":"6","author":"HM Jeong","year":"2017","unstructured":"Jeong HM, Han J, Lee SH, Park HJ, Lee HJ, Choi JS, et al. ESRP1 is overexpressed in ovarian cancer and promotes switching from mesenchymal to epithelial phenotype in ovarian cancer cells. Oncogenesis. 2017;6:e389.","journal-title":"Oncogenesis"},{"key":"3871_CR12","doi-asserted-by":"publisher","first-page":"e47678","DOI":"10.7554\/eLife.47678","volume":"8","author":"J Munkley","year":"2019","unstructured":"Munkley J, Li L, Krishnan SRG, Hysenaj G, Scott E, Dalgliesh C. et al. Androgen-regulated transcription of ESRP2 drives alternative splicing patterns in prostate cancer. Elife. 2019;8:e47678.","journal-title":"Elife"},{"key":"3871_CR13","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.3390\/cancers13164092","volume":"13","author":"M Manco","year":"2021","unstructured":"Manco M, Ala U, Cantarella D, Tolosano E, Medico E, Altruda F. et al. The RNA-Binding Protein ESRP1 Modulates the Expression of RAC1b in Colorectal Cancer Cells. Cancers (Basel). 2021;13:4092.","journal-title":"Cancers (Basel)"},{"key":"3871_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33786-9","volume":"13","author":"J Lee","year":"2022","unstructured":"Lee J, Pang K, Kim J, Hong E, Lee J, Cho HJ, et al. ESRP1-regulated isoform switching of LRRFIP2 determines metastasis of gastric cancer. Nat Commun. 2022;13:6274.","journal-title":"Nat Commun"},{"key":"3871_CR15","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/npp.2012.112","volume":"38","author":"LD Moore","year":"2013","unstructured":"Moore LD, Le T, Fan G. DNA Methylation and Its Basic Function. Neuropsychopharmacology. 2013;38:23\u201338.","journal-title":"Neuropsychopharmacology"},{"key":"3871_CR16","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1158\/1541-7786.MCR-09-0018","volume":"7","author":"S Gopalakrishnan","year":"2009","unstructured":"Gopalakrishnan S, Emburgh BOV, Shan J, Su Z, Fields CR, Vieweg J, et al. A novel DNMT3B splice variant expressed in tumor and pluripotent cells modulates genomic DNA methylation patterns and displays altered DNA binding. Mol Cancer Res. 2009;7:1622\u201334.","journal-title":"Mol Cancer Res"},{"key":"3871_CR17","doi-asserted-by":"publisher","first-page":"28176","DOI":"10.1074\/jbc.M204734200","volume":"277","author":"N Beaulieu","year":"2002","unstructured":"Beaulieu N, Morin S, Chute IC, Robert MF, Nguyen H, MacLeod AR. An essential role for DNA methyltransferase DNMT3B in cancer cell survival. J Biol Chem. 2002;277:28176\u201381.","journal-title":"J Biol Chem"},{"key":"3871_CR18","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/carcin\/bgh307","volume":"26","author":"SJ Lee","year":"2005","unstructured":"Lee SJ, Jeon HS, Jang JS, Park SH, Lee GY, Lee BH, et al. DNMT3B polymorphisms and risk of primary lung cancer. Carcinogenesis. 2005;26:403\u20139.","journal-title":"Carcinogenesis"},{"key":"3871_CR19","first-page":"2113","volume":"17","author":"LH Wang","year":"2018","unstructured":"Wang LH, Huang J, Wu CR, Huang LY, Cui J, Xing ZZ, et al. Downregulation of miR\u201129b targets DNMT3b to suppress cellular apoptosis and enhance proliferation in pancreatic cancer. Mol Med Rep. 2018;17:2113\u201320.","journal-title":"Mol Med Rep"},{"key":"3871_CR20","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1093\/nar\/gkg616","volume":"31","author":"L Cartegni","year":"2003","unstructured":"Cartegni L, Wang J, Zhu Z, Zhang MQ, Krainer AR, ESEfinder:. A web resource to identify exonic splicing enhancers. Nucleic Acids Res. 2003;31:3568\u201371.","journal-title":"Nucleic Acids Res"},{"key":"3871_CR21","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.1093\/hmg\/ddl171","volume":"15","author":"PJ Smith","year":"2006","unstructured":"Smith PJ, Zhang C, Wang J, Chew SL, Zhang MQ, Krainer AR. An increased specificity score matrix for the prediction of SF2\/ASF-specific exonic splicing enhancers. Hum Mol Genet. 2006;15:2490\u2013508.","journal-title":"Hum Mol Genet"},{"key":"3871_CR22","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/s43018-022-00479-7","volume":"4","author":"DY Hyeon","year":"2023","unstructured":"Hyeon DY, Nam D, Han Y, Kim DK, Kim G, Kim D, et al. Proteogenomic landscape of human pancreatic ductal adenocarcinoma in an Asian population reveals tumor cell-enriched and immune-rich subtypes. Nat Cancer. 2023;4:290\u2013307.","journal-title":"Nat Cancer"},{"key":"3871_CR23","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/cancers12082036","volume":"12","author":"M Lee","year":"2020","unstructured":"Lee M, Kwon W, Kim H, Byun Y, Han Y, Kang JS. et al. The Role of Location of Tumor in the Prognosis of the Pancreatic Cancer. Cancers (Basel). 2020;12:2036.","journal-title":"Cancers (Basel)"},{"key":"3871_CR24","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2217\/epi-2017-0093","volume":"10","author":"N Iida","year":"2018","unstructured":"Iida N, Okuda Y, Ogasawara O, Yamashita S, Takeshima H, Ushijima T, et al. a web tool for computing DNA methylation data obtained by the Illumina Infinium Human DNA methylation BeadArray. Epigenomics. 2018;10:249\u201358.","journal-title":"Epigenomics"},{"key":"3871_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1158\/1541-7786.62.2.1","volume":"2","author":"DJ Weisenberger","year":"2004","unstructured":"Weisenberger DJ, Velicescu M, Cheng JC, Gonzales FA, Liang G, Jones PA. Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. Mol Cancer Res. 2004;2:62\u201372.","journal-title":"Mol Cancer Res"},{"key":"3871_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","volume":"619","author":"J Kim","year":"2023","unstructured":"Kim J, Woo S, de Gusmao CM, Zhao B, Chin DH, DiDonato RL, et al. A framework for individualized splice-switching oligonucleotide therapy. Nature. 2023;619:828\u201336.","journal-title":"Nature"},{"key":"3871_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9920230","volume":"2024","author":"B Zardetto","year":"2024","unstructured":"Zardetto B, Lauffer MC, van Roon-Mom W, Aartsma-Rus A. NC On Behalf Of The, Practical Recommendations for the Selection of Patients for Individualized Splice-Switching ASO-Based Treatments. Hum Mutat. 2024;2024:9920230.","journal-title":"Hum Mutat"},{"key":"3871_CR28","doi-asserted-by":"publisher","first-page":"102256","DOI":"10.1016\/j.omtn.2024.102256","volume":"35","author":"B Dume","year":"2024","unstructured":"Dume B, Licarete E, Banciu M. Advancing cancer treatments: The role of oligonucleotide-based therapies in driving progress. Mol Ther Nucleic Acids. 2024;35:102256.","journal-title":"Mol Ther Nucleic Acids"},{"key":"3871_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms11453","volume":"7","author":"CE Duymich","year":"2016","unstructured":"Duymich CE, Charlet J, Yang X, Jones PA, Liang G. DNMT3B isoforms without catalytic activity stimulate gene body methylation as accessory proteins in somatic cells. Nat Commun. 2016;7:11453.","journal-title":"Nat Commun"},{"key":"3871_CR30","doi-asserted-by":"publisher","first-page":"478","DOI":"10.3389\/fcell.2020.00478","volume":"8","author":"J Gong","year":"2020","unstructured":"Gong J, Jie Y, Xiao C, Zhou W, Li X, Chen Y, et al. Increased Expression of Fibulin-1 Is Associated With Hepatocellular Carcinoma Progression by Regulating the Notch Signaling Pathway. Front Cell Dev Biol. 2020;8:478.","journal-title":"Front Cell Dev Biol"},{"key":"3871_CR31","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/s41416-022-01744-3","volume":"126","author":"S Wei","year":"2022","unstructured":"Wei S, Liu W, Xu M, Qin H, Liu C, Zhang R, et al. Cathepsin F and Fibulin-1 as novel diagnostic biomarkers for brain metastasis of non-small cell lung cancer. Br J Cancer. 2022;126:1795\u2013805.","journal-title":"Br J Cancer"},{"key":"3871_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.phrs.2015.05.001","volume":"99","author":"P Zheng","year":"2015","unstructured":"Zheng P, Wang Q, Teng J, Chen J. Calumenin and fibulin-1 on tumor metastasis: Implications for pharmacology. Pharmacol Res. 2015;99:11\u201315.","journal-title":"Pharmacol Res"},{"key":"3871_CR33","doi-asserted-by":"publisher","first-page":"4271","DOI":"10.1158\/0008-5472.CAN-06-4162","volume":"67","author":"SM Pupa","year":"2007","unstructured":"Pupa SM, Giuffre S, Castiglioni F, Bertola L, Cantu M, Bongarzone I, et al. Regulation of breast cancer response to chemotherapy by fibulin-1. Cancer Res. 2007;67:4271\u20137.","journal-title":"Cancer Res"},{"key":"3871_CR34","doi-asserted-by":"publisher","first-page":"27386","DOI":"10.1074\/jbc.M114.589432","volume":"289","author":"H Ishii","year":"2014","unstructured":"Ishii H, Saitoh M, Sakamoto K, Kondo T, Katoh R, Tanaka S, et al. Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms. J Biol Chem. 2014;289:27386\u201399.","journal-title":"J Biol Chem"},{"key":"3871_CR35","doi-asserted-by":"publisher","first-page":"5553","DOI":"10.1038\/sj.onc.1210351","volume":"26","author":"KR Ostler","year":"2007","unstructured":"Ostler KR, Davis EM, Payne SL, Gosalia BB, Exp\u00f3sito-C\u00e9spedes J, Beau MML, et al. Cancer cells express aberrant DNMT3B transcripts encoding truncated proteins. Oncogene. 2007;26:5553\u201363.","journal-title":"Oncogene"},{"key":"3871_CR36","doi-asserted-by":"publisher","first-page":"5840","DOI":"10.1158\/0008-5472.CAN-10-0847","volume":"70","author":"MY Shah","year":"2010","unstructured":"Shah MY, Vasanthakumar A, Barnes NY, Figueroa ME, Kamp A, Hendrick C, et al. DNMT3B7, a truncated DNMT3B isoform expressed in human tumors, disrupts embryonic development and accelerates lymphomagenesis. Cancer Res. 2010;70:5840\u201350.","journal-title":"Cancer Res"},{"key":"3871_CR37","doi-asserted-by":"publisher","first-page":"4984","DOI":"10.1093\/nar\/gkr116","volume":"39","author":"BO Van Emburgh","year":"2011","unstructured":"Van Emburgh BO, Robertson KD. Modulation of Dnmt3b function in vitro by interactions with Dnmt3L, Dnmt3a and Dnmt3b splice variants. Nucleic Acids Research. 2011;39:4984\u20135002.","journal-title":"Nucleic Acids Research"},{"key":"3871_CR38","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1177\/43.4.7534784","volume":"43","author":"EF Roark","year":"1995","unstructured":"Roark EF, Keene DR, Haudenschild CC, Godyna S, Little CD, Argraves WS. The association of human fibulin-1 with elastic fibers: an immunohistological, ultrastructural, and RNA study. J Histochem Cytochem. 1995;43:401\u201311.","journal-title":"J Histochem Cytochem"},{"key":"3871_CR39","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/S0945-053X(98)90114-7","volume":"17","author":"JL Barth","year":"1998","unstructured":"Barth JL, Argraves KM, Roark EF, Little CD, Argraves WS. Identification of chicken and C. elegans fibulin-1 homologs and characterization of the C. elegans fibulin-1 gene. Matrix Biol. 1998;17:635\u201346.","journal-title":"Matrix Biol"},{"key":"3871_CR40","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/sj.bjc.6600802","volume":"88","author":"LM Greene","year":"2003","unstructured":"Greene LM, Twal WO, Duffy MJ, McDermott EW, Hill AD, O\u2019Higgins NJ, et al. Elevated expression and altered processing of fibulin-1 protein in human breast cancer. Br J Cancer. 2003;88:871\u20138.","journal-title":"Br J Cancer"},{"key":"3871_CR41","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1038\/sj.onc.1207323","volume":"23","author":"SM Pupa","year":"2004","unstructured":"Pupa SM, Argraves WS, Forti S, Casalini P, Berno V, Agresti R, et al. Immunological and pathobiological roles of fibulin-1 in breast cancer. Oncogene. 2004;23:2153\u201360.","journal-title":"Oncogene"},{"key":"3871_CR42","first-page":"314","volume":"10","author":"A Aksoy","year":"2023","unstructured":"Aksoy A, Artas G, Kuloglu T, Koc M. Fibulin1 and mesothelin expressions in pancreas ductal adenocarcinoma. North Clin Istanb. 2023;10:314\u201321.","journal-title":"North Clin Istanb"},{"key":"3871_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.omton.2024.200908","volume":"32","author":"S Khurshid","year":"2024","unstructured":"Khurshid S, Venkataramany AS, Montes M, Kipp JF, Roberts RD, Wein N, et al. Employing splice-switching oligonucleotides and AAVrh74.U7 snRNA to target insulin receptor splicing and cancer hallmarks in osteosarcoma. Mol Ther Oncol. 2024;32:200908.","journal-title":"Mol Ther Oncol"},{"key":"3871_CR44","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13046-025-03279-w","volume":"44","author":"X Lv","year":"2025","unstructured":"Lv X, Sun X, Gao Y, Song X, Hu X, Gong L, et al. Targeting RNA splicing modulation: new perspectives for anticancer strategy?. J Exp Clin Cancer Res. 2025;44:32.","journal-title":"J Exp Clin Cancer Res"}],"container-title":["Oncogene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03871-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03871-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T22:02:33Z","timestamp":1786399353000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41388-026-03871-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":44,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026,9,1]]}},"alternative-id":["3871"],"URL":"https:\/\/doi.org\/10.1038\/s41388-026-03871-0","relation":{},"ISSN":["0950-9232","1476-5594"],"issn-type":[{"value":"0950-9232","type":"print"},{"value":"1476-5594","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"4 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Seong-Jin Kim has personal financial interests as a shareholder in Medpacto Inc. All other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of Woojung Bio Animal facility (Suwon, Korea, Approval No. 2020-128) and all methods were performed in accordance with the relevant guidelines and regulations.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}